New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
11:37 EDTMDT, EWEdwards Lifesciences weakness a buying opportunity, says Canaccord
Canaccord said Edwards Lifesciences is down following Metronic's (MDT) FDA approval for the CoreValve TAVI system, which was a few months earlier than expected but in line with guidance. The analyst continues to expect the FDA's approval of Edwares Lifesciences' SAPIEN XT by mid-2014 but could actually be sooner following the Medtronic's approval. The firm continues to recommend Edwards Lifesciences and reiterates its Buy rating and $78 price target.
News For EW;MDT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 3, 2015
08:37 EDTMDTFlex Pharma announces investment from Medtronic
Subscribe for More Information
March 2, 2015
12:59 EDTMDTAppeals court ruling a positive for NuVasive, says Wells Fargo
Subscribe for More Information
12:54 EDTMDTNuVasive gets mixed appeals court ruling in patent fight with Medtronic
Subscribe for More Information
08:55 EDTMDT, EWEdwards Lifesciences Medtronic likely to get positive catalyst, says Wells Fargo
Subscribe for More Information
February 27, 2015
09:02 EDTMDTMedtronic announces Irish High Court approval of share premium reduction
Subscribe for More Information
February 24, 2015
13:02 EDTMDTMedtronic confirms FDA approval of VenaSeal closure system
Subscribe for More Information
February 23, 2015
08:40 EDTMDTMedtronic acquires Advanced Uro-Solutions, terms not disclosed
Medtronic announced that it has acquired Advanced Uro-Solutions, a privately-held developer of neurostimulation products for the treatment of bladder control issues based in Elizabethton, Tennessee. Terms of the acquisition agreement, which closed in December 2014, were not disclosed.
February 20, 2015
12:19 EDTMDTFDA approves closure system to permanently treat varicose veins
Subscribe for More Information
February 19, 2015
16:15 EDTMDTMedtronic SANTE trial data show sustained safety, improvements in QOLIE-31
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use